The United Laboratories International Holdings Limited
ULIHF
$1.64
-$0.1543-8.60%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.48% | -7.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.48% | -7.20% | |||
| Cost of Revenue | -0.48% | 1.52% | |||
| Gross Profit | -0.48% | -17.18% | |||
| SG&A Expenses | -0.48% | 13.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.48% | -156.29% | |||
| Total Operating Expenses | -0.48% | 1.50% | |||
| Operating Income | -0.48% | -34.90% | |||
| Income Before Tax | -0.48% | -26.21% | |||
| Income Tax Expenses | -0.48% | -45.72% | |||
| Earnings from Continuing Operations | -0.48% | -20.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -0.49% | 265.25% | |||
| Net Income | -0.48% | -20.76% | |||
| EBIT | -0.48% | -34.90% | |||
| EBITDA | -0.48% | -30.21% | |||
| EPS Basic | -0.45% | -20.81% | |||
| Normalized Basic EPS | -0.32% | -33.48% | |||
| EPS Diluted | -0.45% | -20.81% | |||
| Normalized Diluted EPS | -0.32% | -33.48% | |||
| Average Basic Shares Outstanding | 0.00% | -0.02% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.02% | |||
| Dividend Per Share | -0.51% | 78.18% | |||
| Payout Ratio | 0.00% | -- | |||